个人介绍

周永红，讲师，2021年博士毕业于复旦大学，随后于复旦大学开展博士后研究，并获得上海市超级博士后。2023年加入上海大学医学院。

代表性成果以第一作者或者共同第一作者于The Lancet Child & adolescent health、Nature Communications 、CID、EBioMedicine等高水平期刊发表论文12篇，获得发明专利7项。

主要研究领域

主要从事传染病流行病学研究和分子生物学，包括血清流行病学、病原分子诊断等。

代表性学术成果

以第一作者或共同第一作者（标记#）发表的论文

1. Yang J#, Liao Q#, Luo K#, Liu F#, Zhou Y#, Zou G#, Huang W, Yu S, Wei X, Zhou J, Dai B, Qiu Q, Ralf Altmeyer, Hu H, Juliette Paireau, Luo L, Gao L, Birgit Nikolay, Hu S, Xing W, Wu P, H. Rogier van Doorn, Peter W. Horby, Peter Simmonds, Gabriel M Leung, Benjamin J. Cowling, Simon Cauchemez, Yu H. Seroepidemiology of children with enterovirus A71 infections in southern China: longitudinal, population-based cohort studies, 2013-2018. Nature Communications.2022.

2. Zhou Y, Van Tan L, Luo K, Liao Q, Wang L, Qiu Q, Zou G, Liu P, Nguyen AT, Nguyen TTH, He M, Wei X, Yu S, Lam TTY, Cui J, van Doorn HR, Yu H. Genetic variation of multiple serotypes of enteroviruses associated with hand, foot and mouth disease in Southern China. Virol Sin. 2021 Feb; 36(1): 61-74.

3. Song C^#, Li Y^#, Zhou Y^#, Liang L^#, Turtle L, Wang F, Wu P, Qiu Q, Yang J, Wang K, Cui P, Cheng Y, Zhang T, Guo C, Zeng M, Long L, Peiris M, Zhou C, Cowling BJ, Yu H. Enterovirus genomic load and disease severity among children hospitalised with hand, foot and mouth disease. EBioMedicine. 2020; 62(2020)103078.

4. Li Y^#, Zhou Y^#, Cheng Y^#, Wu P, Zhou C, Cui P, Song C, Liang L, Wang F, Qiu Q, Guo C, Zeng M, Long L, Cowling BJ, Yu H. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study. Lancet Child Adolesc Health. 2019; 3(10): 697-704.

5. Gao L#, Zou G#, Liao Q#, Zhou Y#, Liu F, Dai B, Liu J, Chen Z, Xing W, Yang L, Liang H, Zhang Y, Chen Z, Luo L, Li Q, Luo K, Wu P, Mo X, Wang L, Lan K, Horby PW, Cowling BJ, Simmonds P, Altmeyer R, Doorn HR, Yu H. Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical Samples. Clin Infect Dis. 2018;67(11):1729-1735.

6. Zhou Y#, Zhou J#, Yang J#, Qiu Q, Wang L, Yang J, Li Y, Liang L, Peng Cui, Cheng Y, Zheng W, Shi H, Gong H, Wang K, Zhou C, Justin Jang Hann Chu, Yu H. Comparison of Neutralizing Antibody Response Kinetic s in Patients with Hand, Foot, and Mouth Disease Caused by Coxsackievirus A16 or Enterovirus A71: A Longitudinal Cohort Study of Chinese Children, 2017-2019. The Journal of Immunology. 2022; 15;209(2):280-287.

7. Zhou J#, Zhou Y#, Luo K#, Liao Q#, Zheng W, Gong H, Shi H, Zhao S, Wang K, Qiu Q, Dai B, Ren L, Wang L, Gao L, Xu M, Liu N, Lu W, Zheng N, Chen X, Yang J, Chen Z, Simon Cauchemez, Yu H. The transfer of maternal antibodies and dynamics of maternal and natural infection-induced antibodies against coxsackievirus A16 in Chinese children 0-13 years of age: A longitudinal cohort study. BMC Medicine. 2022, 20(1):436.

8. Zhou Y, Zhou C#, Wang K, Qiu Q, Cheng Y, Wang K, Qiu Q, Cheng Y, Li Y, Peng Cui, Liang L, Li P, Deng X, Wang L, Zheng W, Gong H, Wang F, Xu M, Justin Jang Hann Chu, Turtle Lance, Yu H. Diagnostic performance of different specimens for detecting enterovirus A71 in children with hand, foot and mouth disease. Virol Sin. 2022

9. Zhou Y#, Liu G#, Cheng X#, Wang Q, WangB, Zhang H, He Q, Zhang L. Antimicrobial activity of a newly identified Kazal-type serine proteinase inhibitor, CcKPI1, from the jellyfish Cyanea capillata. Int J Biol Macromol. 2018 Feb;107(Pt B):1945-1955.